Avalo Therapeutics, Inc.
USD19.63
+0.34 (+1.76%)
CEO
Garry A. Neil
IPO Date
2015-10-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.45
Prev. Close
$19.29
Day Low
$19.32
Day High
$19.84
52W Low
$4.61
52W High
$24.27
Market Cap
$0.22B
Volume
0.08M
| -1.7 |
| 31 Dec 2023 | FY | 33.3% | -1639.5% | -431.9% | -150.3% | 0.07 | 1.82 | -0.1 |
| 31 Dec 2022 | FY | 81.0% | -230.8% | 381.7% | -124.8% | -1.83 | 0.74 | -1.1 |
| 31 Dec 2021 | FY | 72.4% | -1563.1% | -365.5% | -105.2% | 1.44 | 3.11 | -2.1 |
| 31 Dec 2020 | FY | 95.5% | -947.9% | -258.5% | -145.1% | 0.02 | 1.71 | -3.1 |
| 31 Dec 2019 | FY | 108.4% | -238.1% | -76.6% | -44.5% | 0.01 | 1.46 | -19.2 |
| 31 Dec 2018 | FY | 59.2% | -218.5% | -191.6% | -57.0% | 0.74 | 0.84 | -2.8 |
| 31 Dec 2017 | FY | 97.7% | 42.7% | 42.6% | 27.5% | 0.00 | 0.96 | 5.0 |
| 31 Dec 2016 | FY | -614.6% | -1428.5% | -7957.0% | -285.5% | 11.37 | 1.31 | -0.5 |
| -6.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -33.5% | -24.5% | 0.01 | 14.28 | -1.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -19.9% | -16.4% | 0.01 | 12.44 | -0.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.7% | -9.5% | 0.01 | 22.61 | -1.6 |
| 31 Dec 2024 | Q4 | 54.7% | -18405.7% | -26.6% | -23.4% | 0.00 | 19.96 | -0.6 |
| 30 Sept 2024 | Q3 | 386.7% | 9251.8% | 109.3% | 23.4% | 0.03 | 1.42 | 0.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -723.6% | 90.9% | -0.04 | 0.99 | 0.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 120.0% | -98.0% | -0.01 | 0.52 | -0.0 |
| 31 Dec 2023 | Q4 | 138.7% | -1430.5% | -111.8% | -38.9% | 0.07 | 1.82 | -0.2 |